Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α
- PMID: 21489615
- PMCID: PMC3164978
- DOI: 10.1016/j.jaci.2011.03.007
Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α
References
-
- Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med. 2002;166:445–50. - PubMed
-
- Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol. 1998;101:709–15. - PubMed
-
- Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, et al. Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol. 2004;113:1178–84. - PubMed
-
- Maestrelli P, Boschetto P, Fabbri LM, Mapp CE. Mechanisms of occupational asthma. J Allergy Clin Immunol. 2009;123:531–42. quiz 43–4. - PubMed
-
- Bernstein DI, Wang N, Campo P, Chakraborty R, Smith A, Cartier A, et al. Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol. 2006;97:800–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
